Richard L Leask (Richard Leask)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Cardiovascular Events

Health Information

Top Venues

Molecular and cellular biochemistry

Université McGill

University of Toronto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université McGill Aug 01 2002

Canada

Professor :: Chemical Engineering

Education History

University of Toronto Aug 01 1997 - Jan 01 2002

Canada

PHD :: Institute of Biomedical Engineering

Publications

Adam Schwendt, Joey-Bahige Chammas, Milan Maric, Jim A Nicell, Richard L Leask, Lorraine E Chalifour
Exposure to the non-phthalate plasticizer di-heptyl succinate is less disruptive to C57bl/6N mouse recovery from a myocardial infarction than DEHP, TOTM or related di-octyl succinate. PloS one 18 (7) (2023)
Scott Cooper, Hwee Teoh, Marc Antoine Campeau, Subodh Verma, Richard L Leask
Empagliflozin restores the integrity of the endothelial glycocalyx in vitro. Molecular and cellular biochemistry 459 (1-2) (2019)
Scott Cooper, Alexander Emmott, Karli K McDonald, Marc-Antoine Campeau, Richard L Leask
Increased MMP activity in curved geometries disrupts the endothelial cell glycocalyx creating a proinflammatory environment. PloS one 13 (8) (2018)